Mednet Logo

What is your approach for treating locally-advanced gastric-type adenocarcinoma of the cervix?

When would you use 5-fluorouracil instead of, or in addition to, cisplatin during chemoradiation? When, if ever, would you offer adjuvant hysterectomy after chemoradiation?
Community PollStarted

What is your approach for treating locally-advanced gastric-type adenocarcinoma of the cervix?

216 physicians have voted

Join Mednetto vote and see how they answered.

5 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

We still treat with definitive chemo RT (cis) but if operable, then favor surgery first.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Gynecologic Oncology · Center of Hope
Answered on

Recommendation:

There are no specific guidelines for the management of gastric endocervical adenocarcinoma (GEA), a rare, aggressive, non-HPV associated endocervical malignancy.1 Despite clinical and genomic differences between GEA and HPV-related cervical cancers, locally advanced GEA is generally t...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Harold C Simmons Comprehensive Cancer Center/UT Southwestern
Answered on

We still use standard cisplatin based chemo radiation and image guided adaptive brachytherapy.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Abramson Cancer Center, University of Pennsylvania
Answered on

Same. Pathways for locally advanced are the same with cis-RT. Brachy we aim for higher doses to HRCTV since adeno histology. We don’t perform routine adjuvant hysterectomies. Surgery is reserved for persistent or recurrent disease.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Gynecologic Oncology · Karmanos Cancer Institute, Wayne State University
Answered on

Lack of evidence, of course, doesn't indicate a lack of benefit, but without evidence for benefit to an intervention, I cannot recommend a routine practice that clearly adds morbidity.

Therefore, I favor limiting completion hysterectomy in this case to the rare group of patients who, as NCCN mention...

Join for free or sign in to see the full answer